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Introduction
Somatic mosaicism of NLRP3 has been identified in a
high percentage of “mutation-negative” patients suffering
from chronic infantile neurologic, cutaneous, articular
(CINCA) syndrome.
Objectives
The aim of the study was to detect and quantify low fre-
quency variants of NLRP3 in German patients suffering
from cryopyrin associated periodic fever syndromes
(CAPS) including CINCA, Muckle-Wells syndrome
(MWS), and familial cold autoinflammatory syndrome
(FCAS).
Methods
All exons of NLRP3 were amplified by PCR (30 cycles)
from genomic DNA isolated from PBMCs of healthy con-
trols or CAPS patients. Thereafter, PCR products were
concatenated, fragmented and subjected to NGS fragment
library preparation followed by Illumina short read
sequencing. For SNV calling a customized pipeline on
basis of the GATK pipeline (1000 Genomes project) was
utilized using a 40.000x coverage to assure sufficient sensi-
tivity. In order to determine the accuracy of quantification,
PCR products containing a known heterozygous mutation
(T348M) were mixed with NLRP3 wildtype PCR products
to obtain dilutions of the mutated sequences of 25%,
12.5%, and 6.25%.
Results
We were able to exactly quantify the diluted low fre-
quency mutation (T348M). In one CINCA patient a new
variant (L359S) was detected in 30% of the DNA
sequences that had not been identified by classical Sanger
sequencing of an older sample. Up to now we could not
detect low frequency NLRP3 variants in MWS or in
FCAS patients.
Conclusion
Massive parallel sequencing is a reliable method to quan-
tify low frequency variants of NLRP3. A new NLRP3
mutation could be detected in a patient suffering from
typical CINCA syndrome. Somatic mosaicism may be
less frequent in MWS and FCAS patients. Due to the fact
that more “mutation-negative” CAPS patients need to be
characterized, we will continue with this study.
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